Vestal Point Capital, LP Legend Biotech Corp Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Vestal Point Capital, LP holds 475,000 shares of LEGN stock, worth $17.6 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
475,000
Previous 125,000
280.0%
Holding current value
$17.6 Million
Previous $6.09 Billion
153.75%
% of portfolio
0.92%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
233Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$277 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$252 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$211 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$211 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...